In conclusion, the findings of this study showed that ATO, Simvastatin and their combination exert anti‐neoplastic functions in PCa, possibly by overexpression of pro‐apoptotic BAX, P53, PTEN genes and downregulation of anti‐apoptotic Bcl‐2 gene. This evidence concerns the gene BCL2 and posterior cortical atrophy.